Triamcinolone Alternatives Compared
| Triamcinolone | Taltz | Secukinumab |
|
|---|
| Triamcinolone | Taltz (ixekizumab) | Secukinumab |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Alopecia, Allergic Reactions, Allergic Rhinitis, Adrenocortical Insufficiency, Asthma, Dermatological Disorders, Bursitis, Ankylosing Spondylitis, Berylliosis, Carpal Tunnel Syndrome... View more |
Prescription only
Taltz is a monoclonal antibody that reduces inflammation and may be used to treat conditions such as psoriasis, psoriatic arthritis, or ankylosing spondylitis. It is given by injection just under the... View more |
Prescription only
Prescribed for Ankylosing Spondylitis, Psoriatic Arthritis, Enthesitis-Related Arthritis, Non-Radiographic Axial Spondyloarthritis, Plaque Psoriasis, Psoriasis. secukinumab may also be used for... View more |
Related suggestions Psoriatic Arthritis
|
|||||||||||||||
| More about Triamcinolone | More about Taltz (ixekizumab) | More about Secukinumab | ||||||||||||||||
| Generic Status | ||||||||||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
|||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Triamcinolone has an average rating of 6.5 out of 10 from a total of 176 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 35% reported a negative effect. |
Taltz has an average rating of 6.8 out of 10 from a total of 175 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 26% reported a negative effect. |
Secukinumab has an average rating of 6.0 out of 10 from a total of 215 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 36% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
|
See also: triamcinolone side effects in more detail. |
See also: Taltz side effects in more detail. |
Commonly reported side effects include:
See also: secukinumab side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all triamcinolone prices |
View all Taltz prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Aristospan, Aristospan Intra-Articular, Aristospan Intralesional, Clinacort, Kenalog-10, Kenalog-40, Zilretta |
N/A |
Cosentyx | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
36 hours |
312 hours |
744 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 541 drugs are known to interact with triamcinolone:
|
A total of 198 drugs are known to interact with Taltz:
|
A total of 198 drugs are known to interact with secukinumab:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
December 03, 1957 |
March 22, 2016 |
N/A |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
|
||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.